Lazard Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-588
Closed -$46.4K 1866
2025
Q4
$46.4K Buy
588
+298
+103% +$25.8K ﹤0.01% 1797
2025
Q3
$26.6K Buy
+290
New +$23.6K ﹤0.01% 1759
2025
Q1
Sell
-1,781
Closed -$97K 2297
2024
Q4
$97K Sell
1,781
-3,819
-68% -$219K ﹤0.01% 1801
2024
Q3
$333K Sell
5,600
-1,235
-18% -$75.3K ﹤0.01% 1492
2024
Q2
$434K Buy
+6,835
New +$444K ﹤0.01% 1254
2024
Q1
Sell
-3,022
Closed -$166K 2031
2023
Q4
$166K Hold
3,022
﹤0.01% 1456
2023
Q3
$175K Buy
3,022
+495
+20% +$28.6K ﹤0.01% 1435
2023
Q2
$135K Buy
+2,527
New +$112K ﹤0.01% 1464
2023
Q1
Sell
-1,371
Closed -$55K 2284
2022
Q4
$55K Buy
+1,371
New +$51.5K ﹤0.01% 1758
2016
Q2
Sell
-65,073
Closed -$2.19M 1039
2016
Q1
$2.19M Buy
65,073
+3,683
+6% +$125K ﹤0.01% 599
2015
Q4
$2.77M Buy
+61,390
New +$2.64M 0.01% 607

Other funds holding ANIP